JBS N.V. (JBS) Down 4.7% — Do I End This Experiment?
JBS N.V. (JBS) is under pressure Thursday, last changing hands at $10.76 on the NYSE. That is a $0.61 decline from the prior close of $11.37. The selloff extends a steep slide for the meatpacker, which now trades roughly 42.3% below its 52-week high of $18.65, set on April 10, 2026. Nearly half the stock's value has disappeared in under six months, and a market cap of $12.18B now reflects how much investor confidence in the protein cycle has eroded.
Volume through the session stands at approximately 3.19 million shares, against a 90-day average of about 6.45 million. With the regular session still open, turnover is running at roughly half of a typical full day.
Why JBS N.V. Price is Moving Lower
The clearest driver of Thursday's decline is a new trade barrier in one of JBS's most important export markets. Reuters reported on September 30 that China would impose an additional 55% tariff on Brazilian beef starting October 1, after Brazil exhausted its 1.106-million-tonne 2026 quota on September 29. China's commerce ministry announced the measure. Combined with the existing 12% duty, above-quota shipments now face a total tariff of 67%. That level effectively prices much of Brazil's incremental beef out of the Chinese market for the rest of the year. For JBS, whose Brazilian beef operations are a core part of the business, the tariff threatens export volumes directly. It also raises the risk that redirected Brazilian supply will pressure beef prices in other markets JBS serves.
The selling has been concentrated in companies with Brazil exposure rather than spread across the sector. Tyson Foods (TSN), a U.S. protein peer without the same Brazilian beef exposure, was down only about 0.2% around midday, while JBS was off 3.5% at 12:32 p.m. ET before extending its losses. Broader Consumer Staples names were similarly calm. Archer-Daniels-Midland Company (ADM) slipped 0.33%, and Brazil-based beverage maker Ambev S.A. (ABEV) dipped 0.86%. Both moves are a fraction of JBS's decline, which points squarely at the China tariff rather than a market-wide retreat.
The tariff lands on a company whose fundamentals were already strained. JBS's Q2 report, released on August 10, showed adjusted EPS of $0.20 against a $0.31 consensus estimate, a significant miss. Revenue held up better at $23.9 billion versus the $23.04 billion expected, a 13.8% year-over-year increase. On a GAAP basis, however, JBS posted a loss of $0.10 per share, down from earnings of $0.48 a year earlier. IFRS adjusted EBITDA fell 18.5% to $1.43 billion, and the EBITDA margin narrowed to 6.0% from 8.4%. A business already struggling to convert sales into profit now faces a new obstacle to one of its key export channels. Investors will get the next look at the damage when JBS reports Q3 results, scheduled for November 9.
What is the JBS N.V. Rating - Should I Sell?
Weiss Ratings assigns JBS a C- rating. Current recommendation is Hold. The C- sits at the low end of the Hold range. It reflects a company with a workable balance sheet and reasonable capital productivity, offset by poor shareholder returns, elevated price swings, and an earnings trajectory that has moved in the wrong direction.
The operational case starts with the Good rating on the Efficiency Index. JBS generates a 13.38% return on equity despite a profit margin of just 1.22%. That combination fits a high-volume meat processor that turns over enormous sales relative to its capital base, even when the spread on each pound of protein is razor-thin. The Good rating on the Solvency Index adds that the balance sheet can carry the company through a difficult stretch in the cattle and trade cycle without acute strain. That stability also supports the 8.80% dividend yield, though a payout that high on a stock this depressed partly reflects how far the share price has fallen.
Where the picture deteriorates is in the remaining three indices, all rated Weak. The Weak Growth Index rating can look odd next to 13.82% revenue growth, but top-line expansion has not reached the bottom line. A swing from $0.48 in quarterly EPS a year ago to a GAAP loss, alongside an 18.5% drop in adjusted EBITDA, explains why the Growth Index is not rated higher. The Weak Total Return Index reflects a share price down more than 42% from its April high, a loss that the dividend has come nowhere close to offsetting. Today's tariff-driven drop also shows why the Volatility Index is rated Weak. A single policy decision in Beijing can strip nearly 5% from the stock in one session, a sensitivity that comes with heavy dependence on cross-border protein trade.
Within the Consumer Staples sector, JBS matches Pepsico, Inc. (PEP, C-). It trails Mondelez International, Inc. (MDLZ, C) and Keurig Dr Pepper Inc. (KDP, C), and sits further behind Archer-Daniels-Midland Company (ADM, C+) and Ambev S.A. (ABEV, C+). Those two peers carry more favorable risk/reward profiles in the Weiss framework despite their own commodity and emerging-market exposures.
About JBS N.V.
JBS N.V. (JBS) is a Consumer Staples company and one of the largest protein producers in the world. Founded in Brazil in 1953 and now domiciled in the Netherlands, the company processes beef, pork, chicken, and lamb across operations in Brazil, the United States, Australia, Mexico, and Europe. Its portfolio spans fresh and frozen meat sold to retailers and foodservice customers, along with a growing range of value-added and prepared foods.
The company runs its business through a set of well-known regional brands. Friboi anchors its Brazilian beef business, while Seara serves the Brazilian poultry, pork, and processed foods market. In the United States, JBS operates beef and pork processing under the Swift banner and controls Pilgrim's Pride, one of the country's largest chicken producers, which also owns Moy Park in the United Kingdom and Europe. In Australia, JBS ranks among the leading beef and lamb processors and also produces smallgoods under Primo. Beyond core proteins, JBS monetizes byproducts through leather, collagen, and biodiesel operations.
JBS's competitive position rests on scale and geographic diversification. Its multi-continent footprint lets it shift sourcing and sales among cattle, hog, and poultry cycles in different regions, and its processing capacity gives it purchasing power and cost advantages smaller rivals cannot match. That global reach also exposes the company to trade policy, currency swings, and animal-disease restrictions, all of which can abruptly change access to major importing markets such as China.
Investor Outlook
JBS N.V. (JBS) carries a Weiss Rating of C- (Hold). The new 67% effective Chinese tariff on above-quota Brazilian beef adds a fresh headwind to a business already working through margin compression, which argues for caution rather than bargain-hunting despite the 8.80% yield. Investors should watch for signs of how much Brazilian beef gets redirected and how that affects global prices, as well as whether EBITDA margins stabilize from the 6.0% level when JBS reports Q3 results on November 9. See full rankings of all C- rated Consumer Staples stocks inside the Weiss Stock Screener.
--